Hôpital Cochin

Futó vizsgálatok

• Még nem toboroz

  A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)

  NCT07915219· 3. fázis· Forrás

• Még nem toboroz

  Obinutuzumab in Systemic Sclerosis

  NCT07842523· 2. fázis· Forrás

• Toboroz

  Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse

  NCT07871864· 3. fázis· Forrás

• Még nem toboroz

  Superior Mesenteric Artery First Versus Standard Approach in Pancreaticoduodenectomy

  NCT07547033· Forrás

• Még nem toboroz

  An Open-label Safety, Tolerability and Exploratory Efficacy Clinical Trial of PST-611 in Geographic Atrophy

  NCT07705568· 2. fázis· Forrás

• Toboroz

  A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

  NCT07759245· 2. fázis· Forrás

• Toboroz

  Implementing Low-dose ct Lung Cancer Screening in France.

  NCT07513818· Forrás

• Toboroz

  Prospective Dynamic Cohort Study of Phenotypic Profiles in Patients With Chronic Obstructive Pulmonary Disease

  NCT07627763· Forrás

• Toboroz

  Personalisation of Mean Arterial Pressure in Adult Patients With Cardiogenic Shock

  NCT07345559· Forrás

• Még nem toboroz

  Impact of Comprehensive Geriatric Management on Morbidity and Quality of Life in Elderly Patients Undergoing Major Hepatectomy and Pancreaticoduodenectomy for Cancer

  NCT06999512· 2/3. fázis· Forrás

• Toboroz

  A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

  NCT06570798· 2. fázis· Forrás

• Toboroz

  Randomized Interval Assessment Trial of Lu177-Dotatate in Slowly Progressive G1-2 Advanced Midgut Neuroendocrine Tumors

  NCT06878664· 3. fázis· Forrás

• Toboroz

  The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

  NCT06872892· 3. fázis· Forrás

• Toboroz

  Involvement of General Practitioners in Lung Cancer Screening

  NCT06956040· Forrás

• Még nem toboroz

  Comparison of Elranatamab and Lenalidomide Versus Daratumumab and Lenalidomide as Post-transplant Maintenance Therapy in Patients With Newly Diagnosed Myeloma (ElMMA)

  NCT06931704· 2. fázis· Forrás

• Toboroz

  Analysis of the Effectiveness and Safety of Lorlatinib in Untreated ALK-Positive NSCLC Patients in a French Real-World Context

  NCT06487078· Forrás

• Toboroz

  Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

  NCT06472245· 3. fázis· Forrás

• Toboroz

  Precision Medicine in Alzheimer's Disease : Integration of Resilience Metrics and Risk Factors - Validation Cohort BioCogBank-AD

  NCT06582199· Forrás

• Toboroz

  Medico-economic Evaluation of Robot-assisted Laparoscopy Compared With Conventional Laparoscopy in Hysterectomy for Endometrial Cancer.

  NCT06348719· Forrás

• Toboroz

  Effects of Yoga Therapy in Rehabilitation Compared to Physiotherapy in Moderate Axial Spondyloarthritis (axSPA)

  NCT06083090· Forrás

• Toboroz

  Diagnostic and Prognostic Markers of Endometriosis in Menstrual Blood

  NCT06245512· Forrás

• Toboroz

  Utility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly Dose-dense Regimen in Patients With Poor Prognostic OVARian Cancers Based on the Tumor Unfavorable Primary Chemosensitivity and Incomplete Debulking Surgery

  NCT06476184· 3. fázis· Forrás

• Toboroz

  A Phase 2 study to evaluate the efficacy and safety of selinexor monotherapy in subjects with JAK inhibitor-naïve myelofibrosis and moderate thrombocytopenia.

  2024-511309-47-00· 2. fázis· Forrás

• Toboroz

  Randomized Phase III Trial Testing Maintenance Olaparib Versus Observation After Adjuvant Chemoradiation for p53abn Endometrial Cancer

  NCT06712472· 3. fázis· Forrás

• Toboroz

  FIRST-NEC - A multicenter phase II study evaluating the efficacy and safety of the combination of durvalumab (MEDI 4736) with etoposide and platinum as first line treatment in patients with large-cell neuroendocrine carcinomas (LCNECs) of the lung.

  2023-506590-35-00· 2. fázis· Forrás

• Toboroz

  FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and Platinum

  NCT06393816· 2. fázis· Forrás

• Toboroz

  Impact of a Multidisciplinary Assessment in Day Hospitalization Versus Standard Care on the Deployment of Supportive Oncology Care Recommended by the Personalized Post-cancer Plan in Patients at the End of Initial Treatment for Gynecological Ovarian and Endometrial Cancer Endometrial Cancer

  NCT06553612· Forrás

• Toboroz

  A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia

  NCT05980806· 2. fázis· Forrás

• Toboroz

  MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

  NCT06152575· 3. fázis· Forrás

• Toboroz

  Mechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion

  NCT06247826· Forrás

• Toboroz

  EWALL-PH OBSERVARTORY 2022

  NCT07684131· Forrás

• Toboroz

  ctDNA in CRC Patients Undergoing Curative-intent Surgery for Liver Metastases

  NCT05787197· Forrás

• Fut, nem toboroz

  Evaluation of an Early Radiomic Signature in Patients With Metastatic Pancreatic Adenocarcinoma Treated With First-line Chemotherapy

  NCT07243288· Forrás

• Toboroz

  PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer

  NCT05581121· 3. fázis· Forrás

• Fut, nem toboroz

  Azacitidine Combined With Venetoclax in Patients With Higher-risk Chronic Myelomonocytic Leukemia (AVENHIR)

  NCT05768711· 2. fázis· Forrás

• Toboroz

  Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes After Assisted Reproductive Technology

  NCT05625724· 3. fázis· Forrás

• Fut, nem toboroz

  Genomic and Metabolomic Markers Reflecting the Complications of Hypercortisolism (CUSHINGOMICS)

  NCT04840693· Forrás

• Toboroz

  Maintenance Pembrolizumab at Usual or Low doSE in Non-squamous Lung Cancer: a Non-inferiority Study

  NCT05692999· 3. fázis· Forrás

• Toboroz

  A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.

  NCT05689151· Forrás

• Toboroz

  Cost-utility of Focal HIFU vs Prostatectomy

  NCT05710861· Forrás

• Fut, nem toboroz

  Evaluation of the Efficacy of HIFU Treatment on Rectal Endometriosis Symptoms.

  NCT05755958· Forrás

• Toboroz

  Mapping and Characterization of Alveolar Cells During Smoking and Chronic Obstructive Disease

  NCT05227547· Forrás

• Fut, nem toboroz

  Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome

  NCT05382156· Forrás

• Toboroz

  Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL Study

  NCT04935853· Forrás

• Fut, nem toboroz

  Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line

  NCT05201547· 3. fázis· Forrás

• Toboroz

  Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients

  NCT04698785· 2. fázis· Forrás

• Toboroz

  Phase 2, Open label Study of DS-1062a, an Anti-TROP-2-Antibody-Drug Conjugate (ADC), in patients with advanced and/or unresectable Non-Small Cell Lung Cancer (NSCLC), with biomarker analysis to characterize response to therapy_ ICARUS LUNG 01

  2023-505924-71-00· 2. fázis· Forrás

• Fut, nem toboroz

  Datopotamab Deruxtecan (Dato-DXd, DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung Cancer

  NCT04940325· 2. fázis· Forrás

• Fut, nem toboroz

  A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI

  NCT04825743· 3. fázis· Forrás

• Toboroz

  Molecular Signature From Tumor to Lymph Nodes

  NCT04677205· Forrás

Showing 50 of 64.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Tüdőrák10 toboroz
• Neuroendokrin daganatok4 toboroz
• Méhtestrák3 toboroz
• Bronchiectasis2 toboroz
• Gyermekkori daganatok2 toboroz
• Hasnyálmirigyrák2 toboroz
• Krónikus obstruktív tüdőbetegség (COPD)2 toboroz
• Máj- és epeúti rák2 toboroz
• Mielóma multiplex2 toboroz
• Petefészekrák2 toboroz
• Szarkóma2 toboroz
• Vastagbélrák2 toboroz
• Akut limfoid leukémia (ALL)1 toboroz
• Alzheimer-kór1 toboroz
• Atópiás dermatitisz (ekcéma)1 toboroz
• Coeliac disease1 toboroz
• Endometriózis1 toboroz
• Időskori makuladegeneráció1 toboroz
• Lupus (SLE)1 toboroz
• Méhnyakrák1 toboroz
• Mieloproliferatív neopláziák1 toboroz
• Prosztatarák1 toboroz
• Rheumatoid arthritis1 toboroz
• Spondylitis ankylopoetica (Bechterew-kór)1 toboroz
• Szisztémás szklerózis (szkleroderma)1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Lezárult

  Avoidant and Restrictive Food Intake Disorders (ARFID) in Adolescence: Early Oral Development, Psychopathological Profile and Sensory Integration

  NCT06665802· Forrás

• Lezárult

  A Two-Part Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Repeat Doses of Inhaled ETD001 in People With Cystic Fibrosis

  NCT06478706· 2. fázis· Forrás

• Lezárult

  Validation of KELIM as a Predictive/Prognostic Factor for Maintenance Treatment With iPARP in First-Line Ovarian Cancer

  NCT06660147· Forrás

• Lezárult

  A Study of Tobemstomig Plus Platinum-Based Chemotherapy vs Pembrolizumab Plus Platinum-Based Chemotherapy in Participants With Previously Untreated Non-Small Cell Lung Cancer

  NCT05775289· 2. fázis· Forrás

• Lezárult

  Dupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With Atopic Dermatitis

  NCT05642208· 4. fázis· Forrás

• Lezárult

  A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain

  NCT05560646· 2. fázis· Forrás

• Lezárult

  Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE)

  NCT05308966· Forrás

• Lezárult

  Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma

  NCT05218499· 2/3. fázis· Forrás

• Leállították

  GEN1047 for Solid Tumors - First in Human (FIH) Trial

  NCT05180474· 1/2. fázis· Forrás

• Lezárult

  A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del Mutation

  NCT05076149· 3. fázis· Forrás

• Lezárult

  Zephyr Etude Post-Inscription (French Registry)

  NCT04517916· Forrás

• Lezárult

  A Study of Avutometinib (VS-6766) + Defactinib in Recurrent KRAS G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer

  NCT04620330· 2. fázis· Forrás

• Lezárult

  Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents Versus Everolimus-Eluting Stents in Coronary Artery Disease Patients With Diabetes Mellitus Global

  NCT04236609· Forrás

• Lezárult

  A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice

  NCT03782207· Forrás

• Lezárult

  UTOLA: UTerin OLAparib

  NCT03745950· 2. fázis· Forrás

• Lezárult

  Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer

  NCT03598270· 3. fázis· Forrás

• Lezárult

  Retarded Surgery Following Neoadjuvant Chemotherapy in Advanced Ovarian Cancer

  NCT03579394· Forrás

• Lezárult

  Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699

  NCT03606408· 2. fázis· Forrás

• Lezárult

  Maintenance of Remission With Rituximab Versus Azathioprine for Newly-diagnosed or Relapsing Eosinophilic Granulomatosis With Polyangiitis.

  NCT03164473· 3. fázis· Forrás

• Lezárult

  Immunotherapy With Neo-adjuvant Chemotherapy for OVarian Cancer

  NCT03249142· 1/2. fázis· Forrás

• Lezárult

  ATALANTE: Atezolizumab vs Placebo Phase III Study in Late Relapse Ovarian Cancer Treated With Chemotherapy+Bevacizumab

  NCT02891824· 3. fázis· Forrás

• Lezárult

  Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndrome Low Risk

  NCT02757989· Forrás

• Lezárult

  Avelumab in First-line NSCLC (JAVELIN Lung 100)

  NCT02576574· 3. fázis· Forrás

• Visszavonták

  Pregnancy and Medically Assisted Conception in Rare Diseases

  NCT02450396· Forrás

• Lezárult

  ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)

  NCT02078427· Forrás